AU2001274420A1 - Anhydrous pharmaceutical composition of vancomycin for topical use - Google Patents

Anhydrous pharmaceutical composition of vancomycin for topical use

Info

Publication number
AU2001274420A1
AU2001274420A1 AU2001274420A AU7442001A AU2001274420A1 AU 2001274420 A1 AU2001274420 A1 AU 2001274420A1 AU 2001274420 A AU2001274420 A AU 2001274420A AU 7442001 A AU7442001 A AU 7442001A AU 2001274420 A1 AU2001274420 A1 AU 2001274420A1
Authority
AU
Australia
Prior art keywords
vancomycin
pharmaceutical composition
topical use
anhydrous pharmaceutical
anhydrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274420A
Inventor
Vincenzo De Tommaso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICIO PHARMA CHEMICAL AG
Original Assignee
MICIO PHARMA CHEMICAL AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICIO PHARMA CHEMICAL AG filed Critical MICIO PHARMA CHEMICAL AG
Publication of AU2001274420A1 publication Critical patent/AU2001274420A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001274420A 2000-07-11 2001-07-03 Anhydrous pharmaceutical composition of vancomycin for topical use Abandoned AU2001274420A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH13602000 2000-07-11
CH1360/00 2000-07-11
PCT/IB2001/001176 WO2002004012A1 (en) 2000-07-11 2001-07-03 Anhydrous pharmaceutical composition of vancomycin for topical use

Publications (1)

Publication Number Publication Date
AU2001274420A1 true AU2001274420A1 (en) 2002-01-21

Family

ID=4565412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274420A Abandoned AU2001274420A1 (en) 2000-07-11 2001-07-03 Anhydrous pharmaceutical composition of vancomycin for topical use

Country Status (2)

Country Link
AU (1) AU2001274420A1 (en)
WO (1) WO2002004012A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
CA2606386C (en) * 2005-04-29 2014-06-10 Cubist Pharmaceuticals, Inc. Therapeutic compositions
EP2055309A1 (en) * 2007-10-31 2009-05-06 Pharmatex Italia Srl Vancomycin and Teicoplanin anhydrous formulations for topical use
US9241971B1 (en) 2014-07-18 2016-01-26 Kurobe, Llc Topical vancomycin formulation and methods of use
WO2018017814A1 (en) * 2016-07-20 2018-01-25 President And Fellows Of Harvard College Peptidoglycan glycosyltransferase inhibitors of sed proteins for treating bacterial infections
CN117580591A (en) * 2021-05-28 2024-02-20 盖克基金会 Carbitol-polyol-active agent ternary complex, pharmaceutical composition for topical use comprising said ternary complex, method for obtaining said ternary complex and use thereof in different pathological states
CN115804833A (en) * 2021-09-14 2023-03-17 海南普利制药股份有限公司 Vancomycin gel and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
JP3502574B2 (en) * 1999-06-29 2004-03-02 東亜薬品株式会社 Eye ointment for treatment of eye infections
US6248718B1 (en) * 1999-08-18 2001-06-19 Atlantic Biomed Corporation Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity

Also Published As

Publication number Publication date
WO2002004012A1 (en) 2002-01-17
WO2002004012A8 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002327209A1 (en) Topical composition for treating pain
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2001271931A1 (en) Anhydrous cosmetic compositions
AU2001280499A1 (en) Anhydrous cosmetic compositions
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2001289102A1 (en) Topical formulations for delivery of interleukin-11
AU2002302147A1 (en) Pharmaceutical composition
AU5286901A (en) Topical anesthetic formulation
AU2002258221A1 (en) Medicinal composition
AU2001274420A1 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
AU2002221365A1 (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU2001248943A1 (en) Pharmaceutical curative compound
AU4085201A (en) Pharmaceutical composition
GB9902227D0 (en) Pharmaceutical composition for topical administration
AU2002354460A1 (en) Medicinal composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001274251A1 (en) Novel pharmaceutical formulation suitable for nebulisation
AU2002333193A1 (en) A pharmaceutical composition for dermal application
AUPR529701A0 (en) Pharmaceutical composition
AU2002351722A1 (en) A pharmaceutical composition for dermal application
AU7445601A (en) Pharmaceutical composition for the treatment of multiple sclerosis